Analysis
All Analysis
Filter by
Filtering By:
Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox
Commentary by Sujai Shivakumar and Anne Pritchett — January 13, 2026
Universities, Patents, and the Future of U.S. Competitiveness
Commentary by Shruti Sharma and Chris Borges — December 15, 2025
U.S. Universities: Engines of Economic Growth
Commentary by Sujai Shivakumar, Charles Wessner, Shruti Sharma, and Chris Borges — October 29, 2025
Don’t Tax Invention: The Risks of a Patent Tax
Commentary by Sujai Shivakumar and Chris Borges — September 4, 2025
The United States’ Trade Surplus in Intellectual Property Is a Strategic Asset
Analysis by Alexander Kersten and Chris Borges — June 25, 2025
Innovation Lightbulb: U.S. Patenting Abroad — A Quiet Trade Advantage
Newsletter by Chris Borges — May 23, 2025
Innovation Lightbulb: The U.S. IP Trade Surplus
Newsletter by Chris Borges — May 12, 2025
Protecting Intellectual Property for National Security
Report by Kirti Gupta, Andrei Iancu, Walter G. Copan, and Chris Borges — March 25, 2025
Protecting Intellectual Property for National Security
Transcript — December 3, 2024
Understanding the U.S. Biopharmaceutical Innovation Ecosystem
Report by Sujai Shivakumar, Tisyaketu Sirkar, and Jeffrey Depp — August 15, 2024